← FDA Drug Approvals (Drugs@FDA)

AMINOCAPROIC ACID

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2025-05-19

Drug application

FDA Application #

ANDA213216

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMINOCAPROIC ACID

Generic name

AMINOCAPROIC ACID

Active ingredients

AMINOCAPROIC ACID

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Apozeal Pharmaceuticals Inc.

First approval

2025-05-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown